Title |
SLC45A3-ELK4 Is a Novel and Frequent Erythroblast Transformation–Specific Fusion Transcript in Prostate Cancer
|
---|---|
Published in |
Cancer Research, April 2009
|
DOI | 10.1158/0008-5472.can-08-4926 |
Pubmed ID | |
Authors |
David S. Rickman, Dorothee Pflueger, Benjamin Moss, Vanessa E. VanDoren, Chen X. Chen, Alexandre de la Taille, Rainer Kuefer, Ashutosh K. Tewari, Sunita R. Setlur, Francesca Demichelis, Mark A. Rubin |
Abstract |
Chromosomal rearrangements account for all erythroblast transformation-specific (ETS) family member gene fusions that have been reported in prostate cancer and have clinical, diagnostic, and prognostic implications. Androgen-regulated genes account for the majority of the 5' genomic regulatory promoter elements fused with ETS genes. TMPRSS2-ERG, TMPRSS2-ETV1, and SLC45A3-ERG rearrangements account for roughly 90% of ETS fusion prostate cancer. ELK4, another ETS family member, is androgen regulated, involved in promoting cell growth, and highly expressed in a subset of prostate cancer, yet the mechanism of ELK4 overexpression is unknown. In this study, we identified a novel ETS family fusion transcript, SLC45A3-ELK4, and found it to be expressed in both benign prostate tissue and prostate cancer. We found high levels of SLC45A3-ELK4 mRNA restricted to a subset of prostate cancer samples. SLC45A3-ELK4 transcript can be detected at high levels in urine samples from men at risk for prostate cancer. Characterization of the fusion mRNA revealed a major variant in which SLC45A3 exon 1 is fused to ELK4 exon 2. Based on quantitative PCR analyses of DNA, unlike other ETS fusions described in prostate cancer, the expression of SLC45A3-ELK4 mRNA is not exclusive to cases harboring a chromosomal rearrangement. Treatment of LNCaP cancer cells with a synthetic androgen (R1881) revealed that SLC45A3-ELK4, and not endogenous ELK4, mRNA expression is androgen regulated. Altogether, our findings show that SLC45A3-ELK4 mRNA expression is heterogeneous, highly induced in a subset of prostate cancers, androgen regulated, and most commonly occurs through a mechanism other than chromosomal rearrangement (e.g., trans-splicing). |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 3% |
Norway | 1 | 1% |
Hungary | 1 | 1% |
Canada | 1 | 1% |
Brazil | 1 | 1% |
Unknown | 91 | 93% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 30 | 31% |
Student > Ph. D. Student | 27 | 28% |
Student > Master | 8 | 8% |
Professor | 6 | 6% |
Other | 6 | 6% |
Other | 14 | 14% |
Unknown | 7 | 7% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 38 | 39% |
Biochemistry, Genetics and Molecular Biology | 25 | 26% |
Medicine and Dentistry | 14 | 14% |
Computer Science | 7 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 1% |
Other | 2 | 2% |
Unknown | 11 | 11% |